LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method
- PMID: 17118610
- DOI: 10.1016/j.jpba.2006.10.013
LC and LC-MS study of stress decomposition behaviour of isoniazid and establishment of validated stability-indicating assay method
Abstract
Isoniazid was subjected to different ICH prescribed stress conditions of thermal stress, hydrolysis, oxidation and photolysis. The drug was stable to dry heat (50 and 60 degrees C). It showed extensive decomposition under hydrolytic conditions, while it was only moderately sensitive to oxidation stress. The solid drug turned intense yellow on exposure to light under accelerated conditions of temperature (40 degrees C) and humidity (75% RH). In total, three major degradation products were detected by LC. For establishment of stability-indicating assay, the reaction solutions in which different degradation products were formed were mixed, and the separation was optimized by varying the LC conditions. An acceptable separation was achieved using a C-18 column and a mobile phase comprising of water:acetonitrile (96:4, v/v), with flow rate and detection wavelength being 0.5 ml min(-1) and 254 nm, respectively. The degradation products appeared at relative retention times (RR(T)) of 0.71, 1.34 and 4.22. The validation studies established a linear response of the drug at concentrations between 50 and 1000 microg ml(-1). The mean values (+/-R.S.D.) of slope, intercept and correlation coefficient were 35,199 (+/-0.88), 114,310 (+/-4.70) and 0.9998 (+/-0.01), respectively. The mean R.S.D. values for intra- and inter-day precision were 0.24 and 0.90, respectively. The recovery of the drug ranged between 99.42 and 100.58%, when it was spiked to a mixture of solutions in which sufficient degradation was observed. The specificity was established through peak purity testing using a photodiode array detector. The method worked well on application to marketed formulation of isoniazid, and a fixed-dose combination containing isoniazid and ethambutol HCl. It was even extendable to LC-MS studies, which were carried out to identify the three degradation products. The m/z values of the peaks at RR(T) 0.71 and RR(T) 1.34 matched with isonicotinic acid and isonicotinamide, respectively. The product appearing at RR(T) 4.22 was isolated using preparative LC-MS, and turned out to be a yellow compound that was identified as isonicotinic acid N'-(pyridyl-4-carbonyl)-hydrazide based on mass, FTIR and (1)H/(13)C NMR spectral data. The same was indicated to be responsible for discolouration of isoniazid bulk drug substance and formulations, which is a familiar problem. The mechanism of formation of the said compound is outlined.
Similar articles
-
LC and LC-MS/MS study of forced decomposition behavior of anastrozole and establishment of validated stability-indicating analytical method for impurities estimation in low dose anastrozole tablets.J Pharm Biomed Anal. 2009 Oct 15;50(3):397-404. doi: 10.1016/j.jpba.2009.05.025. Epub 2009 May 30. J Pharm Biomed Anal. 2009. PMID: 19541446
-
Study of forced degradation behavior of eletriptan hydrobromide by LC and LC-MS and development of stability-indicating method.J Pharm Biomed Anal. 2009 Nov 1;50(4):622-9. doi: 10.1016/j.jpba.2009.01.034. Epub 2009 Feb 6. J Pharm Biomed Anal. 2009. PMID: 19250786
-
Validated specific HPLC method for determination of zidovudine during stability studies.J Pharm Biomed Anal. 2005 Apr 29;37(5):1109-14. doi: 10.1016/j.jpba.2004.09.013. J Pharm Biomed Anal. 2005. PMID: 15862693
-
The use of liquid chromatography-mass spectrometry for the identification of drug degradation products in pharmaceutical formulations.Biomed Chromatogr. 2000 Oct;14(6):384-96. doi: 10.1002/1099-0801(200010)14:6<384::AID-BMC30>3.0.CO;2-D. Biomed Chromatogr. 2000. PMID: 11002276 Review.
-
Applications of hyphenated LC-MS techniques in pharmaceutical analysis.Biomed Chromatogr. 2000 Oct;14(6):373-83. doi: 10.1002/1099-0801(200010)14:6<373::AID-BMC29>3.0.CO;2-S. Biomed Chromatogr. 2000. PMID: 11002275 Review.
Cited by
-
Sodium Hyaluronate Nanocomposite Respirable Microparticles to Tackle Antibiotic Resistance with Potential Application in Treatment of Mycobacterial Pulmonary Infections.Pharmaceutics. 2019 May 1;11(5):203. doi: 10.3390/pharmaceutics11050203. Pharmaceutics. 2019. PMID: 31052403 Free PMC article.
-
(E)-6,6'-(Diazene-1,2-di-yl)bis-(1,10-phenanthrolin-5-ol) tri-chloro-methane disolvate: a superconjugated ligand.Acta Crystallogr E Crystallogr Commun. 2019 Jul 23;75(Pt 8):1224-1227. doi: 10.1107/S205698901900954X. eCollection 2019 Aug 1. Acta Crystallogr E Crystallogr Commun. 2019. PMID: 31417796 Free PMC article.
-
A DFT study on non-enzymatic degradations of anti-tuberculosis drug isoniazid.J Mol Model. 2023 Aug 24;29(9):291. doi: 10.1007/s00894-023-05700-7. J Mol Model. 2023. PMID: 37615715
-
Isoniazid hair drug levels among TB patients as a tool to monitor adherence, exposure, and TB treatment outcomes and its acceptability in a multicultural setting. A narrative review.Afr Health Sci. 2023 Dec;23(4):28-34. doi: 10.4314/ahs.v23i4.5. Afr Health Sci. 2023. PMID: 38974301 Free PMC article. Review.
-
D-π-A Carbzazole Based Reactive Cyano-Substituted C = C bond Probe for Selective and Sensitive Detection of Hydrazine in Aqueous Media.J Fluoresc. 2025 May;35(5):3331-3342. doi: 10.1007/s10895-024-03768-9. Epub 2024 May 18. J Fluoresc. 2025. PMID: 38761323
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous